XML 49 R37.htm IDEA: XBRL DOCUMENT v3.24.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Jul. 07, 2017
Net income (loss) $ 59,000   $ (1,221,000)      
Cash used in operations     1,453,000      
Cash and cash equivalents 809,000   809,000      
Allowance For Doubtful Accounts 1,271,000   1,271,000   $ 1,495,000  
Inventory Reserve 95,000   95,000   $ 95,000  
Warranty Reserve 30,000   30,000      
Advertising And Promotional Expenses 35,000 $ 66,000 192,000 $ 405,000    
Research And Development Expenses 56,000 $ 76,000 $ 186,000 $ 221,000    
Cash Balances At Financial Institutions $ 250,000          
Shares of common stock outstanding 20,015,205   20,015,205   19,923,955  
Common Stock, Shares Authorized 250,000,000   250,000,000   250,000,000  
Convertible debentures            
Potentially Dilutive Securities 2,080,000   2,080,000      
Stock Options            
Potentially Dilutive Securities 63,750 610,500 63,750 610,500    
Preferred A stock            
Potentially Dilutive Securities 63,750 63,750 63,750 63,750    
2016 Equity Incentive Plan            
Shares of common stock outstanding 5,700,000 3,400,000 5,700,000 3,400,000    
Common Stock, Shares Authorized           2,000,000
2016 Equity Incentive Plan | Director [Member]            
Common Stock, Shares Issued     60,000      
Two Vendors | Accounts Payable            
Concentration Risk, Percentage         59.00%  
Two Vendors | Cost of Sales [Member]            
Concentration Risk, In Percentage 53.00% 60.00% 65.00% 72.00%    
One Vendors | Accounts Payable            
Concentration Risk, Percentage 56.00%   56.00%      
Warrants            
Potentially Dilutive Securities 2,765,846 2,773,585 2,765,846 2,773,585